Narrative updates are currently in beta.

Back to narrative

Update shared on09 Aug 2025

Fair value Increased 1.08%
AnalystConsensusTarget's Fair Value
Col$58,700.67
1.5% overvalued intrinsic discount
15 Aug
Col$59,560.00
Loading
1Y
66.0%
7D
4.7%

With both the discount rate and revenue growth forecasts holding steady, there has been no material change to Grupo Cibest’s fair value, as the consensus analyst price target remains unchanged at COP58076.


What's in the News


  • Special/Extraordinary Shareholders Meetings scheduled.
  • Agenda includes proposals for board compensation at both BancoColombia S.A. and Grupo Cibest S.A.
  • Consideration of general authorization for recurring and ordinary course transactions between BancoColombia S.A. and Grupo Cibest S.A.

Valuation Changes


Summary of Valuation Changes for Grupo Cibest

  • The Consensus Analyst Price Target remained effectively unchanged, at COP58076.
  • The Discount Rate for Grupo Cibest remained effectively unchanged, at 17.93%.
  • The Consensus Revenue Growth forecasts for Grupo Cibest remained effectively unchanged, at 14.3% per annum.

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.